REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 130.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 15.00 (11.538%)
Open: 137.50
High: 137.50
Low: 137.50
Prev. Close: 137.50
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Oct 2021 07:00

RNS Number : 0774O
Manolete Partners PLC
06 October 2021
 

06 October 2021

 

MANOLETE PARTNERS PLC

 

("Manolete" or the "Company")

Trading Update

 

In June 2020 the UK Government reacted to the Covid-19 pandemic by suppressing UK insolvencies through the use of various "Temporary Measures" contained in the Corporate Insolvency and Governance Act 2020. These measures largely ended, effective from 1 October 2021 as did a number of other business support schemes, including furlough. Manolete's trading for the interim six-month reporting period ended 30 September 2021 was during the time that these "Temporary Measures" were in full effect. Despite these unprecedented restrictions, the Company has performed well and in line with the Board's expectations during the period.

During the six months ending 30 September 2021 (all figures unaudited):

- 64 cases were completed (23% higher than the 52 case completions in H1 FY21).

- Those 64 cases were settled for an aggregate settlement value of £7.9m.

- The average duration of the 64 cases from the date of signing the investment agreement to the date the case was legally settled was 11.5 months, which is in line with the Company's long-term average.

- The Return on Investment of those 64 cases was 157% which represents a Money Multiple of 2.57x (meaning every £1 Manolete invested into those cases returns £2.57).

- 255 new UK insolvency case enquiries were received, which was 5% higher than the previous six months but 24% below H1 FY21 which was affected far less by the Temporary Measures referred to above.

- 78 new case investments were made (11% lower than the previous six months, which underlines Manolete's high standards of rigorous case assessment and 29% below H1 FY21).

- £4.3m of cash was received from previously completed cases.

50 new UK insolvency case enquiries were received in the month of September 2021, the highest level the Company has experienced since July 2020.

Manolete started the second half of its financial year with 262 live cases in progress.

As at 30 September 2021, Manolete had drawn down £11m from its £25m three-year Revolving Credit Facility with HSBC.

Half year results for the six months ended 30 September 2021 will be announced by the Company next month.

 

Steven Cooklin, CEO of Manolete, commented:

"The Manolete business has performed admirably despite the extraordinary temporary measures enacted by the UK Government designed to suppress UK insolvencies and to support UK employment levels. Effective from the start of this month, those measures have now very largely ended with a return to broadly normal insolvency processes.

"As can be seen from the data released by the UK Insolvency Service, the number of monthly Creditors Voluntary Liquidations had already bounced back to pre-pandemic levels for each of the last four months.

"There is always a time lag between an insolvency appointment, investigation work being done by the Insolvency Practitioner and then cases being referred to Manolete, but we are now starting to see the increased number of insolvency appointments being reflected in our KPIs - September saw the highest level of new case enquiries being received since July 2020. We also witnessed a strong recovery in our numbers of new signed cases at 15 for that month, 50% higher than the previous month. Even with this sharp upturn these KPIs are still far below the level we were experiencing before the Government instigated the necessary economic support measures so we anticipate further strong growth in the number of signed cases in the months ahead.

"With a return to largely normal UK insolvency processes from 1 October 2021, Manolete is well positioned to benefit from that and the likely, widely predicted, increase in insolvency appointments as the economy realigns from the effects of the pandemic".

 

For further information please contact:

 

 

Manolete Partners: 

Steven Cooklin (Chief Executive Officer) via Instinctif Partners

 

Peel Hunt (NOMAD and Broker) +44 (0)20 7418 8900 

James Britton

Rishi Shah

 

Instinctif Partners (Financial PR) manolete@instinctif.com / +44 (0)20 7457 2020

Tim Linacre

George Peele

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVORRAAURRAA
Date   Source Headline
8th May 20247:00 amRNSAppointment of New External Audit Firm
2nd May 20247:00 amRNSChange of Auditor
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 202111:03 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.